This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, W.
Right arrow Articles by Imperiale, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, W.
Right arrow Articles by Imperiale, M. J.

 Previous Article  |  Next Article 

Journal of Virology, November 2001, p. 10446-10454, Vol. 75, No. 21
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.21.10446-10454.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Role for the Adenovirus IVa2 Protein in Packaging of Viral DNA

Wei Zhang, Jonathan A. Low, Joan B. Christensen, and Michael J. Imperiale*

Department of Microbiology and Immunology, Center for Gene Therapy and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109-0942

Received 21 June 2001/Accepted 6 August 2001

Although it has been demonstrated that the adenovirus IVa2 protein binds to the packaging domains on the viral chromosome and interacts with the viral L1 52/55-kDa protein, which is required for viral DNA packaging, there has been no direct evidence demonstrating that the IVa2 protein is involved in DNA packaging. To understand in greater detail the DNA packaging mechanisms of adenovirus, we have asked whether DNA packaging is serotype or subgroup specific. We found that Ad7 (subgroup B), Ad12 (subgroup A), and Ad17 (subgroup D) cannot complement the defect of an Ad5 (subgroup C) mutant, pm8001, which does not package its DNA due to a mutation in the L1 52/55-kDa gene. This indicates that the DNA packaging systems of different serotypes cannot interact productively with Ad5 DNA. Based on this, a chimeric virus containing the Ad7 genome except for the inverted terminal repeats and packaging sequence from Ad5 was constructed. This chimeric virus replicates its DNA and synthesizes Ad7 proteins, but it cannot package its DNA in 293 cells or 293 cells expressing the Ad5 L1 52/55-kDa protein. However, this chimeric virus packages its DNA in 293 cells expressing the Ad5 IVa2 protein. These results indicate that the IVa2 protein plays a role in viral DNA packaging and that its function is serotype specific. Since this chimeric virus cannot package its own DNA, but produces all the components for packaging Ad7 DNA, it may be a more suitable helper virus for the growth of Ad7 gutted vectors for gene transfer.


* Corresponding author. Mailing address: University of Michigan Medical School, 1500 E. Medical Center Dr., 6310 Cancer Center, Ann Arbor, MI 48109-0942. Phone: (734) 763-9162. Fax: (734) 615-6560. E-mail: imperial{at}umich.edu.


Journal of Virology, November 2001, p. 10446-10454, Vol. 75, No. 21
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.21.10446-10454.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Jesus, D. M., Costa, L. T., Goncalves, D. L., Achete, C. A., Attias, M., Moussatche, N., Damaso, C. R. (2009). Cidofovir Inhibits Genome Encapsidation and Affects Morphogenesis during the Replication of Vaccinia Virus. J. Virol. 83: 11477-11490 [Abstract] [Full Text]  
  • Yang, Z., Zhu, Z., Tang, L., Wang, L., Tan, X., Yu, P., Zhang, Y., Tian, X., Wang, J., Zhang, Y., Li, D., Xu, W. (2009). Genomic Analyses of Recombinant Adenovirus Type 11a in China. J. Clin. Microbiol. 47: 3082-3090 [Abstract] [Full Text]  
  • Morris, S. J., Leppard, K. N. (2009). Adenovirus Serotype 5 L4-22K and L4-33K Proteins Have Distinct Functions in Regulating Late Gene Expression. J. Virol. 83: 3049-3058 [Abstract] [Full Text]  
  • Ostapchuk, P., Hearing, P. (2008). Adenovirus IVa2 Protein Binds ATP. J. Virol. 82: 10290-10294 [Abstract] [Full Text]  
  • Wohl, B. P., Hearing, P. (2008). Role for the L1-52/55K Protein in the Serotype Specificity of Adenovirus DNA Packaging. J. Virol. 82: 5089-5092 [Abstract] [Full Text]  
  • Tyler, R. E., Ewing, S. G., Imperiale, M. J. (2007). Formation of a Multiple Protein Complex on the Adenovirus Packaging Sequence by the IVa2 Protein. J. Virol. 81: 3447-3454 [Abstract] [Full Text]  
  • Ali, H., LeRoy, G., Bridge, G., Flint, S. J. (2007). The Adenovirus L4 33-Kilodalton Protein Binds to Intragenic Sequences of the Major Late Promoter Required for Late Phase-Specific Stimulation of Transcription. J. Virol. 81: 1327-1338 [Abstract] [Full Text]  
  • Ostapchuk, P., Anderson, M. E., Chandrasekhar, S., Hearing, P. (2006). The L4 22-Kilodalton Protein Plays a Role in Packaging of the Adenovirus Genome. J. Virol. 80: 6973-6981 [Abstract] [Full Text]  
  • Zhang, Q., Su, X., Gong, S., Zeng, Q., Zhu, B., Wu, Z., Peng, T., Zhang, C., Zhou, R. (2006). Comparative genomic analysis of two strains of human adenovirus type 3 isolated from children with acute respiratory infection in southern China. J. Gen. Virol. 87: 1531-1541 [Abstract] [Full Text]  
  • Perez-Romero, P., Gustin, K. E., Imperiale, M. J. (2006). Dependence of the Encapsidation Function of the Adenovirus L1 52/55-Kilodalton Protein on Its Ability To Bind the Packaging Sequence. J. Virol. 80: 1965-1971 [Abstract] [Full Text]  
  • Xiao, F., Moll, W.-D., Guo, S., Guo, P. (2005). Binding of pRNA to the N-terminal 14 amino acids of connector protein of bacteriophage phi29. Nucleic Acids Res 33: 2640-2649 [Abstract] [Full Text]  
  • Ostapchuk, P., Yang, J., Auffarth, E., Hearing, P. (2005). Functional Interaction of the Adenovirus IVa2 Protein with Adenovirus Type 5 Packaging Sequences. J. Virol. 79: 2831-2838 [Abstract] [Full Text]  
  • Purkayastha, A., Ditty, S. E., Su, J., McGraw, J., Hadfield, T. L., Tibbetts, C., Seto, D. (2005). Genomic and Bioinformatics Analysis of HAdV-4, a Human Adenovirus Causing Acute Respiratory Disease: Implications for Gene Therapy and Vaccine Vector Development. J. Virol. 79: 2559-2572 [Abstract] [Full Text]  
  • Lauer, K. P., Llorente, I., Blair, E., Seto, J., Krasnov, V., Purkayastha, A., Ditty, S. E., Hadfield, T. L., Buck, C., Tibbetts, C., Seto, D. (2004). Natural variation among human adenoviruses: genome sequence and annotation of human adenovirus serotype 1. J. Gen. Virol. 85: 2615-2625 [Abstract] [Full Text]  
  • Johnson, J. S., Osheim, Y. N., Xue, Y., Emanuel, M. R., Lewis, P. W., Bankovich, A., Beyer, A. L., Engel, D. A. (2004). Adenovirus Protein VII Condenses DNA, Represses Transcription, and Associates with Transcriptional Activator E1A. J. Virol. 78: 6459-6468 [Abstract] [Full Text]  
  • Xing, L., Zhang, L., Kessel, J. V., Tikoo, S. K. (2003). Identification of cis-acting sequences required for selective packaging of bovine adenovirus type 3 DNA. J. Gen. Virol. 84: 2947-2956 [Abstract] [Full Text]  
  • Erturk, E., Ostapchuk, P., Wells, S. I., Yang, J., Gregg, K., Nepveu, A., Dudley, J. P., Hearing, P. (2003). Binding of CCAAT Displacement Protein CDP to Adenovirus Packaging Sequences. J. Virol. 77: 6255-6264 [Abstract] [Full Text]  
  • Ostapchuk, P., Hearing, P. (2003). Minimal cis-Acting Elements Required for Adenovirus Genome Packaging. J. Virol. 77: 5127-5135 [Abstract] [Full Text]  
  • Zhang, W., Imperiale, M. J. (2003). Requirement of the Adenovirus IVa2 Protein for Virus Assembly. J. Virol. 77: 3586-3594 [Abstract] [Full Text]  
  • Harada, J. N., Shevchenko, A., Shevchenko, A., Pallas, D. C., Berk, A. J. (2002). Analysis of the Adenovirus E1B-55K-Anchored Proteome Reveals Its Link to Ubiquitination Machinery. J. Virol. 76: 9194-9206 [Abstract] [Full Text]  
  • Rademaker, H. J., El Hassan, M. A. A., Versteeg, G. A., Rabelink, M. J. W. E., Hoeben, R. C. (2002). Efficient mobilization of E1-deleted adenovirus type 5 vectors by wild-type adenoviruses of other serotypes. J. Gen. Virol. 83: 1311-1314 [Abstract] [Full Text]